Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

OBJECT: The authors assessed the safety and maximum tolerated dose of superselective intraarterial cerebral infusion (SIACI) of bevacizumab after osmotic disruption of the blood-brain barrier (BBB) with mannitol in patients with recurrent malignant glioma. METHODS: A total of 30 patients with recurr...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Boockvar, John A., Tsiouris, Apostolos J., Hofstetter, Christoph P., Kovanlikaya, Ilham I, Fralin, Sherese, Kesavabhotla, Kartik, Seedial, Stephen M., Pannullo, Susan C., Schwartz, Theodore H., Stieg, Philip, Zimmerman, Robert D., Knopman, Jared, Scheff, Ronald J., Christos, Paul, Vallabhajosula, Shankar, Riina, Howard A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2010
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3622705/
https://ncbi.nlm.nih.gov/pubmed/20964595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2010.9.JNS101223
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन